#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic angiosarcoma Epilepsy with myoclonic-atonic seizures B-cell type acute leukaemia Dent's disease Demyelination Postprandial hypoglycaemia Hereditary angioedema with C1 esterase inhibitor deficiency Granulomatosis with polyangiitis Glomerulonephritis acute Angiosarcoma metastatic B-cell small lymphocytic lymphoma Rett syndrome Mitochondrial encephalomyopathy Pemphigus Malignant neoplasm of choroid More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Treatment Osteosarcoma – Treatment Familial amyotrophic lateral sclerosis Focal segmental glomerulosclerosis – Basic Information Breast angiosarcoma Idiopathic pulmonary fibrosis – Treatment Bronchiolitis obliterans syndrome – Life with Disease Mantle cell lymphoma – Trials in Disease Nephroblastoma – Trials in Disease Medulloblastoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enmetazobactam Methotrexate Sodium F770/05 Montelukast Tirzepatide NALDEMEDINE Iomeprol Chlortalidone Trandolapril Glycerol Phenylbutyrate Nitric Oxide Terbinafine Human Serum Albumin 5% Bisoprolol Diclofenac Sodium GSKVX000000044501 Ict01 Erythromycin Fipaxalparant Aluminium Hydroxide More therapies…

    Learn about Your Condition

    Procedural haemorrhage Optic ischaemic neuropathy Neurofibrosarcoma Bile acid synthesis disorder Hepatic neoplasm Mitral valve disease Milk allergy Congenital ureteric anomaly Alveolar proteinosis Bacterial infection Circulatory collapse Agitation postoperative Bone marrow disorder Ovarian epithelial cancer Multiple system atrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer

  • Study on Doxorubicin Hydrochloride and Trabectedin for Patients with Recurrent Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Trabectedin
    • Doxorubicin Hydrochloride
    Italy

  • Study of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Relacorilant
    • Paclitaxel Albumin-Bound
    Belgium France Hungary Italy Poland Spain

  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    • Hepatobiliary cancer
    • T-cell lymphoma
    Investigated Drugs:
    • Fadraciclib
    Spain

  • Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Nemvaleukin Alfa
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    Austria Belgium Czechia Denmark France Germany +4

  • Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Bladder cancer
    • Gastric cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Germany

  • Study on the Safety and Tolerability of KAND567 and Carboplatin for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • (2R)-2-[[2-Amino-5-[(1S)-1-Phenylethyl]Sulfanyl-[1,3]Thiazolo[4,5-D]Pyrimidin-7-Yl]Amino]-4-Methylpentan-1-Ol Hydrochloride
    • Carboplatin
    Denmark Norway Sweden
Previous Page
1 … 9 10 11 12 13 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!